Contraline Raises $92.5M to advance NES/T Gel and expand its male reproductive health pipeline and clinical development ...

Amid shifts in attitudes around family planning and contraception—and as the advent of telehealth outfits like Hims & Hers ...

The Google Ventures-backed company could become the first to commercialise a reversible male contraceptive drug, provided the ...

In this episode, they turn their attention to male contraception. We’ve been hearing about a “male pill” for decades, so why ...

Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily ...

Proceeds from the Series B financing will support the late-stage development of NES/T Gel, an investigational hormonal, reversible male contraceptive with first-in-class potential. NES/T is a ...

Explore India's contraceptive landscape and the crucial need for women's reproductive agency through insights from NFHS-6 ...

Drs Chris and Xand van Tulleken take a closer look at the future of male contraception.

The use of modern contraceptive methods among married women in India has marginally declined over the past few years, while reliance on traditional methods of family planning has seen an increase, ...

Contraception is not just about preventing an unwanted pregnancy. Experts say it’s also an important part of adolescent ...

The NFHS-6 survey shows a decline in the use of modern contraceptive methods among married women in India and a rise in traditional family planning methods. Experts have expressed concern, warning tha ...

It was found that a significant number of women in their 20s and 30s still rely on the withdrawal method or the calendar-based method, rather than mod ...